Shopping Cart
Remove All
Your shopping cart is currently empty
AI-10-104 acts as an inhibitor of the runt-related transcription factor (RUNX), increasing cytotoxic effects in myeloma cells [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,650 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $2,240 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,760 | 4-6 weeks | 4-6 weeks |
| Description | AI-10-104 acts as an inhibitor of the runt-related transcription factor (RUNX), increasing cytotoxic effects in myeloma cells [1]. |
| In vitro | AI-10-104 (0-10 μM) inhibits RUNX by dissociating the RUNXs-IKZFs complex, thereby enhancing the antiproliferative and cytotoxic effects of lenalidomide (CC-5013) on myeloma cells [1]. Western Blot analysis [1], using a concentration of 0-10 μM in HEK293T cells, shows a reduction in IKZF3 and CBFβ levels. Cell proliferation assays [1] conducted on OPM-1, KMS-11, and U266 cell lines at a concentration of 1 μM revealed maintained cell viability with moderate inhibition of OPM-1 cell proliferation. |
| Molecular Weight | 309.24 |
| Formula | C14H10F3N3O2 |
| Cas No. | 1881276-00-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.